Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Medicenna Therapeutics Inc.
DescriptionHuman pro-apoptotic Type 1 IL-4 fusion
Molecular Target Interleukin-4 (IL-4) receptor (CD124) (IL-4RA)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationHematologic malignancies
Indication DetailsTreat blood cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today